Lv69
2220 积分 2025-09-11 加入
路漫漫其修远兮,吾将上下而求索。
LBO-001 Tirzepatide for the treatment of metabolic dysfunction-associated steatohepatitis with liver fibrosis: results of the SYNERGY-NASH phase 2 trial
24天前
已关闭
Efficacy of tirzepatide in glycemic control and weight management in adults with type 2 diabetes: a systematic review and meta-analysis of real-world studies
24天前
已完结
Tirzepatide for Metabolic Dysfunction–Associated Steatohepatitis with Liver Fibrosis
24天前
已完结
EE16 PROJECTED LIFETIME IMPACT OF TIRZEPATIDE ON HEALTH AND ECONOMIC OUTCOMES FOR MODERATE-TO-SEVERE OSA WITH OBESITY: A CHINESE MODELING ANALYSIS
26天前
已关闭
Clinical Impact of Tirzepatide on Patients With OSA and Obesity
26天前
已完结
Obstructive Sleep Apnea and Cardiometabolic Disease: Obesity, Hypertension, and Diabetes
26天前
已完结
Tirzepatide for Weight Reduction in Chinese Adults With Obesity
29天前
已完结
Tirzepatide for Metabolic Dysfunction–Associated Steatohepatitis with Liver Fibrosis
29天前
已完结
PT37 EFFECTIVENESS AND SAFETY OF GLP-1 RECEPTOR AGONISTS IN PATIENTS WITH WEIGHT RECURRENCE AFTER BARIATRIC SURGERY: A REAL-WORLD STUDY
30天前
已完结
Real‐World Effectiveness and Safety of GLP ‐1 Receptor Agonists Among Patients With Weight Recurrence After Bariatric Surgery
30天前
已完结